The Terry Fox Research Institute has co-funded six Master’s and PhD students and one postdoctoral…
karnottFebruary 1, 2024
About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb…
karnottJanuary 31, 2024
Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and…
karnottJanuary 30, 2024
Microbion Corporation announced that the company has been granted a second orphan drug designation for…
karnottJanuary 30, 2024
The Michael Smith Laboratories is pleased to highlight one of our outstanding graduate students, Heather…
karnottJanuary 29, 2024
The College and Community Innovation (CCI) program’s Mobilize grants 2024 competition, managed by the Natural…
karnottJanuary 29, 2024
Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, presented positive Phase 2 safety and…
karnottJanuary 26, 2024
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a…
karnottJanuary 26, 2024
